Vericiguat Disease Interactions
There are 2 disease interactions with vericiguat:
Vericiguat (Includes vericiguat) hepatic impairment
Moderate Potential Hazard, Moderate plausibility. Applies to: Liver Disease
Vericiguat has not been studied in patients with severe hepatic impairment (Child-Pugh C). Caution is advised. No dosage adjustment is recommended in patients with mild or moderate hepatic impairment (Child-Pugh A or B).
Vericiguat (Includes vericiguat) renal impairment
Moderate Potential Hazard, Moderate plausibility. Applies to: Renal Dysfunction
Vericiguat has not been studied in patients with eGFR <15 mL/min/1.73m2 or on dialysis. Caution is advised. No dose adjustment is required for patients with eGFR >15 mL/min/1.73m2 not on dialysis.
Vericiguat drug interactions
There are 5 drug interactions with vericiguat
More about vericiguat
Related treatment guides
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No interaction information available.|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.